Telstar’s centre in the UK consolidates its business growth with move to new higher-capacity modern installation
Specialised in aseptic and containment barrier Isolation technology systems, Telstar UK has seen increased demand for its products from all across the life sciences sector has grown significantly in the past few years.
Telstar’s centre in the UK expands production capacity with a move to new premises in Birstall, Leeds, a large modern facility that will enable the company to virtually triple its production capacity and to support an increasing global customer base. The company is relocating from Shaw Cross Business Park, Dewsbury, to new premises on Dark Lane, Birstall, Leeds close to the M62 and M621 motorways.
Telstar’s centre of excellence in the UK has experienced a substantial growth in aseptic and containment Isolator requirements, particularly in respect of aseptic processing and filling line applications, throughout recent years. The new facility offers a space adapted to the specific conditions and requirements for environmental quality, manufacturing and qualification of equipment for the pharmaceutical, biotechnology and cell therapy industries. It has a comprehensive production plant for the manufacture of highly complex and demanding Isolator systems, as well as expansive two storey offices, modern meeting rooms, canteen, warehouse and loading bays. The new facility will accommodate technical engineering, customer services and a dedicated sales team and admin support services.
Telstar is a leading global brand of aseptic process solutions. The company provides complete systems, integrating barrier systems with either in-house process equipment or third-party equipment with the ability to provide complete turnkey solutions. Part of the azbil Group, Telstar is acknowledged as one of the 10 major suppliers to the pharmaceutical industry. The company has a solid commitment with a continuous development of technologies for the life science markets and a robust background endorsed by the development of more than 1,700 installations of integrated process equipment & systems for over 50 years. Telstar also has a consolidated activity in engineering & construction of complete turnkey pharmaceutical and biotech production facilities, critical installations, clean rooms, and R&D laboratories.
The company, which invests three percent of its turnover in research, development and innovation of its technologies and equipment, operates in over a hundred countries and has four production plants, seven technology centres and 12 consultancy and engineering services centres, as well as commercial offices all over the world. It has manufacturing plants in Spain, China and the UK. Headquartered in Terrassa (Barcelona, Spain), it has a workforce of 900 people.